Bioinformatic Analysis of Therapeutic Phages for Phage Therapy

Added:

Intro to Phage Therapy
Lytic vs. Lysogenic
Sequencing Analysis
Gene Family Search
Genome Annotation
Predicting Lifestyle
Web-Based Tools
Expert Q&A Part 1
Expert Q&A Part 2
Expert Q&A Part 3

Intro to Phage Therapy

0:01
Playing Section
  • 1

    Explains the mission of the center for personalized phage therapy.

  • 2

    Outlines the process of treating patients with chronic infections.

  • 3

    Highlights the advantages of using phages against antibiotic-resistant bacteria.

Understanding of bacteriophage biology, specifically the structural and functional differences between the lytic and lysogenic life cycles.
Fundamental knowledge of genomics, including DNA sequencing technologies (NGS), genome assembly, and basic annotation concepts.
Familiarity with basic bioinformatic sequence alignment tools and public databases, such as NCBI BLAST and UniProt.
An understanding of bacterial virulence factors, antibiotic resistance genes, and the mechanisms of horizontal gene transfer.
In vitro validation methods, such as host range determination, plaque assays, and confirming the lack of lysogenic conversion in the wet lab.
Genetic engineering of phages, including the use of CRISPR-Cas systems to remove toxic genes or expand host range synthetically.
Regulatory requirements and safety guidelines (e.g., FDA or EMA frameworks) for approving personalized and cocktail-based phage therapies.
Metagenomic and ecological analysis of the human microbiome to monitor phage-host dynamics and evolutionary resistance development in vivo.
3.5K views106likes54:52@BCMTAILORLabsOriginal Release: 2021-05-03

Therapeutic phages must undergo rigorous bioinformatic screening to ensure safety, including checking for antibiotic resistance genes, virulence factors, lysogenic cycle markers (like integrases), and confirming they are strictly lytic phages; this involves genome assembly, taxonomic classification, gene family analysis, structural and functional annotation, and lifestyle prediction using multiple computational tools to prove beyond reasonable doubt that the phage will not cause harm in patients.